Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Ann Intern Med. 2012 Apr 17;156(8):551-9. doi: 10.7326/0003-4819-156-8-201204170-00397.
Perineural inhibitors of tumor necrosis factor have recently generated intense interest as an alternative to epidural steroid injections for lumbosacral radiculopathy.
To evaluate whether epidural steroids, etanercept, or saline better improves pain and function in adults with lumbosacral radiculopathy.
A multicenter, 3-group, randomized, placebo-controlled trial conducted from 2008 to 2011. Randomization was computer-generated and stratified by site. Pharmacists prepared the syringes. Patients, treating physicians, and nurses assessing outcomes were blinded to treatment assignment. (ClinicalTrials.gov registration number: NCT00733096)
Military and civilian treatment centers.
84 adults with lumbosacral radiculopathy of less than 6 months' duration.
2 epidural injections of steroids, etanercept, or saline, mixed with bupivacaine and separated by 2 weeks.
The primary outcome measure was leg pain 1 month after the second injection. All patients had 1-month follow-up visits; patients whose condition improved remained blinded for the 6-month study period.
The group that received epidural steroids had greater reductions in the primary outcome measure than those who received saline (mean difference, -1.26 [95% CI, -2.79 to 0.27]; P = 0.11) or etanercept (mean difference, -1.01 [CI, -2.60 to 0.58]; P = 0.21). For back pain, smaller differences favoring steroids compared with saline (mean difference, -0.52 [CI, -1.85 to 0.81]; P = 0.44) and etanercept (mean difference, -0.92 [CI,-2.28 to 0.44]; P = 0.18) were observed. The largest differences were noted for functional capacity, in which etanercept fared worse than the other treatments: steroids vs. etanercept (mean difference, -16.16 [CI, -26.05 to -6.27]; P = 0.002), steroids vs. saline (mean difference, -5.87 [CI, -15.59 to 3.85]; P = 0.23), and etanercept vs. saline (mean difference, 10.29 [CI, 0.55 to 20.04]; P = 0.04). More patients treated with epidural steroids (75%) reported 50% or greater leg pain relief and a positive global perceived effect at 1 month than those who received saline (50%) or etanercept (42%) (P = 0.09).
Short-term follow-up, small sample size, and a possibly subtherapeutic dose of etanercept.
Epidural steroid injections may provide modest short-term pain relief for some adults with lumbosacral radiculopathy, but larger studies with longer follow-up are needed to confirm their benefits.
The John P. Murtha Neuroscience and Pain Institute, International Spinal Intervention Society, and Center for Rehabilitation Sciences Research.
最近,肿瘤坏死因子的周围神经抑制剂作为腰骶神经根病硬膜外类固醇注射的替代方法引起了极大的兴趣。
评估硬膜外类固醇、依那西普和生理盐水在治疗腰骶神经根病方面是否能更好地改善疼痛和功能。
一项多中心、3 组、随机、安慰剂对照试验,于 2008 年至 2011 年进行。随机化由计算机生成,并按地点分层。药剂师制备注射器。患者、治疗医生和评估结果的护士对治疗分配情况不知情。(临床试验.gov 注册号:NCT00733096)
军事和民用治疗中心。
84 例腰骶神经根病病程少于 6 个月的成年人。
2 次硬膜外注射类固醇、依那西普或生理盐水,与布比卡因混合,间隔 2 周。
主要结局指标是第二次注射后 1 个月的腿部疼痛。所有患者均进行了 1 个月的随访;病情改善的患者在 6 个月的研究期间保持盲法。
接受硬膜外类固醇治疗的组与接受生理盐水(平均差异,-1.26 [95%CI,-2.79 至 0.27];P = 0.11)或依那西普(平均差异,-1.01 [CI,-2.60 至 0.58];P = 0.21)治疗的组相比,主要结局指标的降低更大。对于背痛,与生理盐水(平均差异,-0.52 [CI,-1.85 至 0.81];P = 0.44)和依那西普(平均差异,-0.92 [CI,-2.28 至 0.44];P = 0.18)相比,接受类固醇治疗的组较小的差异有利于类固醇。在功能能力方面观察到最大的差异,依那西普的效果不如其他治疗方法:类固醇与依那西普(平均差异,-16.16 [CI,-26.05 至-6.27];P = 0.002)、类固醇与生理盐水(平均差异,-5.87 [CI,-15.59 至 3.85];P = 0.23)和依那西普与生理盐水(平均差异,10.29 [CI,0.55 至 20.04];P = 0.04)。接受硬膜外类固醇治疗的患者(75%)比接受生理盐水(50%)或依那西普(42%)治疗的患者(P = 0.09)报告腿部疼痛缓解 50%或更多且总体感知效果良好的比例更高。
短期随访、样本量小和依那西普可能的亚治疗剂量。
硬膜外类固醇注射可能为一些腰骶神经根病患者提供短期疼痛缓解,但需要进行更大规模、随访时间更长的研究以确认其益处。
John P. Murtha 神经科学和疼痛研究所、国际脊柱介入学会和康复科学研究中心。